ERBB2 and breast cancer: More recently, it has been shown that the curcuminoid demethoxycurcumin enhanced the chemotherapeutic efficacy of cisplatin on HER2-overexpressing BC cells and inhibited the HER2-induced drug resistance of tumor cells through the inhibition of the PI3K/AKT signaling pathway[22].